US Follows WHO: Monkeypox Is a Public Health Emergency
The declaration will allow more funds for control of and resources for the disease.
Monkeypox (Adobe Stock)
This article was originally published in Contagionlive.com.
US Health Secretary Xavier Becerra declared a national public health emergency for monkeypox.
“In light of evolving circumstances on the ground, I am declaring a public health emergency on #monkeypox. We are prepared to take our response to the next level in addressing this virus. We urge every American to take monkeypox seriously," Becerra, tweeted on August 4.
The declaration mobilizes the response and opens up federal funding to address the virus.
As of yesterday, there has been 6617 confirmed cases with California and New York having the most cases. Earlier this week, California Governor Gavin Newsom declared a state of emergency with regards to the monkeypox outbreak. This came on the heels of San Francisco and New York City declaring states of emergency along with New York State’s declaration that monkeypox is an "imminent threat to public health," over the last week. Shortly before that, World Health Organization declared monkeypox a “global health emergency.”
The US federal agencies are making vaccines and treatment available. For example, CDC and FDA have developed a process to help clinicians secure an antiviral therapy, tecovirimat (Tpoxx), for treatment for patients with monkeypox. This falls under the expanded access investigational new drug (EA-IND). Clinicians can begin the process to secure tecovirimat by going here.
Tecovirimat is manufactured by SIGA Technologies, and is approved for smallpox and is being studied for monkeypox treatment. Infection Control Today®’s (ICT®’s) sister publication, Contagion Live, spoke with SIGA Technologies Chief Scientific Officer Dennis Hruby, PhD, recently about the therapy.
The federal government has also been sending out vaccines to prevent the spread of monkeypox. At this point in time, it has been reported that only people who are close personal contacts of people who have contracted the virus are eligible to get access to the vaccines.
ICT® gives details about monkeypox, what it is and how it is spread, here.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
